Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 7
Submit an article Journal homepage
64
Views
26
CrossRef citations to date
0
Altmetric
Review

The adverse prognostic impact of advanced age in multiple myeloma

Linda Mileshkin Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, AustraliaCorrespondence[email protected]
&
H Miles Prince Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia
Pages 951-966 | Received 05 Feb 2005, Published online: 03 Aug 2009

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jörgen Möller, Lars Nicklasson & Ananthram Murthy. (2011) Cost-effectiveness of novel relapsed-refractory multiple myeloma therapies in Norway: lenalidomide plus dexamethasone vs bortezomib. Journal of Medical Economics 14:6, pages 690-697.
Read now
Mustaqeem Siddiqui & Morie Gertz. (2008) The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myeloma. Leukemia & Lymphoma 49:8, pages 1436-1451.
Read now
Federica Cavallo, Maria Teresa Ambrosini, Cecilia Rus, Mario Boccadoro & Antonio Palumbo. (2007) The treatment of the elderly multiple myeloma patients. Leukemia & Lymphoma 48:3, pages 469-480.
Read now
H. Miles Prince, Brad Schenkel & Linda Mileshkin. (2007) An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma. Leukemia & Lymphoma 48:1, pages 46-55.
Read now

Articles from other publishers (22)

Paul A. Hamlin, Vasile Musteata, Steven I. Park, Christine Burnett, Kristina Dabovic, Thomas Strack, Eric T. Williams, Banmeet S. Anand, Jack P. Higgins & Daniel O. Persky. (2022) Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. Cancer Research Communications 2:5, pages 307-315.
Crossref
Sung Min Kim, Silvia Park, Dong Ryul Oh, Yong Chan Ahn, Young Hyeh Ko, Seok Jin Kim & Won Seog Kim. (2016) Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability. Annals of Hematology 95:4, pages 581-591.
Crossref
Ruben NiesvizkyIan W. FlinnRobert RifkinNashat GabrailVeena CharuBilly ClowneyJames EssellYousuf GaffarThomas WarrRachel NeuwirthYanyan ZhuJennifer ElliottDixie-Lee EsseltineLiviu NiculescuJames Reeves. (2015) Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens. Journal of Clinical Oncology 33:33, pages 3921-3929.
Crossref
Roberto Castelli, Giuseppe Pantaleo, Paolo Gallipoli, Antonio Gidaro, Massimo Arquati, Maddalena A. Wu & Giorgio Lambertenghi Deliliers. (2015) Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma. Anti-Cancer Drugs 26:10, pages 1078-1082.
Crossref
Jesús F. San-Miguel, Ramón García-Sanz & Norma C. Gutiérrez. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 615 636 .
Asher A. Chanan-Khan, Sagar Lonial, Donna Weber, Ivan Borrello, Robin Foà, Andrzej Hellmann, Meletios Dimopoulos, Arlene S. Swern & Robert Knight. (2012) Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma. International Journal of Hematology 96:2, pages 254-262.
Crossref
Sheng-Hsiang Yang, Hao-Wei Teng, Ying-Chung Hong, Chun-Yu Liu, Yuan-Bin Yu, Ching-Fen Yang, Jyh-Pyng Gau, Jin-Hwang Liu, Tai-Jay Chang, Jeffrey J. Y. Yen, Po-Min Chen, Tzeon-Jye Chiou, Cheng-Hwai Tzeng & Liang-Tsai Hsiao. (2011) International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents. Annals of Hematology 91:1, pages 93-102.
Crossref
Janet K. Horton, John F. GleasonJr.Jr., Heidi D. Klepin, Scott Isom, Daniel B. Fried & Ann M. Geiger. (2011) Age‐related disparities in the use of radiotherapy for treatment of localized soft tissue sarcoma. Cancer 117:17, pages 4033-4040.
Crossref
Gareth J. MorganFaith E. DaviesWalter M. GregoryNigel H. RussellSue E. BellAlexander J. SzubertNuria Navarro CoyGordon CookSylvia FeylerJenny L. ByrneHuw RoddieClaudius RudinMark T. DraysonRoger G. OwenFiona M. Ross, Graham H. Jackson & J. Anthony Child. (2011) Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation. Blood 118:5, pages 1231-1238.
Crossref
Heidi D. Klepin & David D. Hurd. 2010. Allogeneic Stem Cell Transplantation. Allogeneic Stem Cell Transplantation 127 142 .
Cyrille HulinThierry FaconPhilippe RodonBrigitte PegourieLotfi BenboubkerChantal DoyenMamoun DibGaelle GuillermBruno SallesJean-Paul EschardPascal LenainPhilippe CasassusIsabelle AzaïsOlivier DecauxLaurent GarderetClaire MathiotJean FontanIngrid LafonJean Marc VirionPhilippe Moreau. (2009) Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial. Journal of Clinical Oncology 27:22, pages 3664-3670.
Crossref
Antonio Palumbo, Valeria Magarotto, Alessandra Larocca, Sara Bringhen, Patrizia Falco, Francesco Di Raimondo, Luca Baldini & Mario Boccadoro. (2008) Treatment of newly diagnosed multiple myeloma. Current Hematologic Malignancy Reports 3:2, pages 107-114.
Crossref
Hermann Brenner, Adam Gondos & Dianne Pulte. (2008) Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 111:5, pages 2521-2526.
Crossref
Martin Görner & Ernst Späth-Schwalbe. (2008) Modern Treatment Options for Elderly Patients with Multiple Myeloma. Onkologie 31:6, pages 10-10.
Crossref
S K Kumar, S R Hayman & R A Kyle. (2007) Autologous stem cell transplantation in the elderly including pre- and post-treatment options. Bone Marrow Transplantation 40:12, pages 1115-1121.
Crossref
Rafael Fonseca & Jesus San Miguel. (2007) Prognostic Factors and Staging in Multiple Myeloma. Hematology/Oncology Clinics of North America 21:6, pages 1115-1140.
Crossref
Jesús F. San Miguel, Ramón García-Sanz & Norma C. Gutiérrez. 2007. Multiple Myeloma: Translational and Emerging Therapies. Multiple Myeloma: Translational and Emerging Therapies 115 140 .
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Jesús-F. San Miguel, Jamie D. Cavenagh & Kenneth C. Anderson. (2007) Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma. British Journal of Haematology 137:5, pages 429-435.
Crossref
Hang Quach, H Miles Prince & Linda Mileshkin. (2007) Treatment Strategies in Elderly Patients with Multiple Myeloma. Drugs & Aging 24:10, pages 829-850.
Crossref
M. Kenealy & H. M. Prince. (2006) Current status of new drugs for the treatment of patients with multiple myeloma. Internal Medicine Journal 36:12, pages 781-789.
Crossref
H D Klepin & D D Hurd. (2006) Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?. Bone Marrow Transplantation 38:9, pages 585-592.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:3-4, pages 136-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.